Sol-Gel Technologies (NASDAQ:SLGL) reported quarterly losses of $(0.25) per share. This is a 28.57 percent increase over losses of $(0.35) per share from the same period last year.
What’s Going On With CRISPR Therapeutics Stock?
CRISPR Therapeutics AG (NASDAQ: CRSP) shares are trading higher Monday after Morgan Stanley maintained the company with an Underweight rating and lowered the price target.
What To Know: